Literature DB >> 12928276

Severe infective keratitis leading to hospital admission in New Zealand.

T Wong1, S Ormonde, G Gamble, C N J McGhee.   

Abstract

AIM: To identify key risk factors and the management and outcome of severe infective keratitis leading to public hospital admission in New Zealand.
METHODS: Over a 2 year period, all admissions of presumed infective keratitis to Auckland Hospital were identified. The clinical records of all 103 cases were retrospectively reviewed with respect to clinical features, risk factors, management, and outcomes.
RESULTS: The mean time from first symptoms or signs and presentation to hospital was 8.9 (SD 15.5) days. The majority of subjects, 88%, had at least one of the risk factors commonly associated with infective keratitis including previous ocular surgery (30%), contact lens wear (26%), topical corticosteroid use (25%), and ocular trauma (24%). Corneal scraping was performed in 92% and of a total of 105 scrapes, 71% were positive. Bacteria were isolated in all these cases, the majority being Gram positive organisms (72%). The most common isolates identified were coagulase negative Staphylococcus (16%), Propionibacterium acnes (14%), Staphylococcus epidermidis (11%), and Streptococcus pneumoniae (9%). In addition, yeasts were isolated in 5%, fungi in 4%, virus in 2%, and chlamydia in 1%. Importantly, polymicrobial infection accounted for 33% of culture positive cases. Antimicrobial treatment was changed on the basis of culture results in 17 cases (16.5%). Median initial visual and final best corrected visual acuity was 6/36-6/48 (logMAR 0.86) (IQR 0.39-2.00) and 6/12-6/15 (logMAR 0.360) (IQR 0.15-1.70), respectively. Previous ocular surgery and topical corticosteroid use were significantly associated with poorer visual acuity. The mean hospital stay was 5.8 days and the median 4.0 (IQR 2.0-8.0) days. Longer duration of stay was associated with the presence of hypopyon, larger ulcers, previous ocular surgery, and poor visual acuity.
CONCLUSIONS: Infectious keratitis is an important cause of ocular morbidity. A significant proportion of cases have potentially modifiable risk factors. Previous ocular surgery and topical corticosteroid use, in particular, were associated with poorer visual outcomes. Many cases of severe keratitis might be avoided, or their severity reduced, by appropriate education of patients and ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928276      PMCID: PMC1771869          DOI: 10.1136/bjo.87.9.1103

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  29 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis.

Authors:  D J Coster; P R Badenoch
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

3.  Management of bacterial corneal ulcers.

Authors:  R Maske; J C Hill; S P Oliver
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

4.  Antimicrobial activity of topical anaesthetic preparations.

Authors:  P R Badenoch; D J Coster
Journal:  Br J Ophthalmol       Date:  1982-06       Impact factor: 4.638

5.  Epidemiology of microbial keratitis in southern California. A multivariate analysis.

Authors:  L D Ormerod; E Hertzmark; D S Gomez; R G Stabiner; D J Schanzlin; R E Smith
Journal:  Ophthalmology       Date:  1987-10       Impact factor: 12.079

6.  Bacterial keratitis: a prospective clinical and microbiological study.

Authors:  F Schaefer; O Bruttin; L Zografos; Y Guex-Crosier
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

Review 7.  The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970-2000.

Authors:  J Baum; M Barza
Journal:  Cornea       Date:  2000-09       Impact factor: 2.651

8.  Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.

Authors:  N Morlet; D Minassian; J Butcher
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

9.  The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis.

Authors:  S D McLeod; A Kolahdouz-Isfahani; K Rostamian; C W Flowers; P P Lee; P J McDonnell
Journal:  Ophthalmology       Date:  1996-01       Impact factor: 12.079

10.  Causation and management of microbial keratitis in subtropical Africa.

Authors:  L D Ormerod
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

View more
  34 in total

Review 1.  Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis.

Authors:  F Stapleton; N Carnt
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

2.  Epidemiological, clinical and laboratory findings of infectious keratitis at Mansoura Ophthalmic Center, Egypt.

Authors:  Amani E Badawi; Dalia Moemen; Nora L El-Tantawy
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

3.  Polymicrobial infection and the eye.

Authors:  S Tuft
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

4.  Early addition of topical corticosteroids in the treatment of bacterial keratitis.

Authors:  Kathryn J Ray; Muthiah Srinivasan; Jeena Mascarenhas; Revathi Rajaraman; Meenakshi Ravindran; David V Glidden; Catherine E Oldenburg; Catherine Q Sun; Michael E Zegans; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  JAMA Ophthalmol       Date:  2014-06       Impact factor: 7.389

5.  Vincamine prevents lipopolysaccharide induced inflammation and oxidative stress via thioredoxin reductase activation in human corneal epithelial cells.

Authors:  Li Wu; Meihong Ye; Jie Zhang
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

6.  Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis.

Authors:  Melissa E Sanders; Nathan A Tullos; Sidney D Taylor; Erin W Norcross; Lauren B King; Isaiah Tolo; Mary E Marquart
Journal:  Curr Eye Res       Date:  2010-12       Impact factor: 2.424

7.  Microbiological findings and predisposing risk factors in corneal ulcers.

Authors:  Verena Prokosch; Zisis Gatzioufas; Solon Thanos; Tobias Stupp
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-25       Impact factor: 3.117

8.  Infective keratitis in older patients: a 4 year review, 1998-2002.

Authors:  T K H Butler; N A Spencer; C C K Chan; J Singh Gilhotra; K McClellan
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

9.  Risk factors for perforation in microbial corneal ulcers in north India.

Authors:  J S Titiyal; S Negi; A Anand; R Tandon; N Sharma; R B Vajpayee
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

10.  Risk factors, microbial profiles and prognosis of microbial keratitis-associated endophthalmitis in high-risk eyes.

Authors:  Evelyn C O'Neill; Jonathan Yeoh; David C A Fabinyi; Dermot Cassidy; Rasik B Vajpayee; Penelope Allen; Paul P Connell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.